NEW DELHI — In an unprecedented display of economic solidarity and legislative protest, nearly 12.4 lakh traditional retail chemists, pharmacists, and drug distributors across India launched a massive nationwide strike on May 20. The 24-hour shutdown, engineered by the All India Organisation of Chemists and Druggists (AIOCD), completely disrupted routine over-the-counter medicine distribution in several major states, including Maharashtra, Gujarat, Delhi, and Rajasthan.
The extensive operational freeze highlights a multi-year, systemic conflict within the national pharmaceutical sector. Brick-and-mortar storefront owners argue that the rapid, unchecked rise of corporate-backed e-pharmacies and instant delivery apps is single-handedly forcing independent family businesses into bankruptcy while actively endangering public health and drug safety.
AIOCD Nationwide Strike Breakdown (May 20)
=========================================================
[Closed] ████████████████████████████████ 80% Standalone Retail Stores
[Open] ███████ 20% Emergency, Hospital, & Govt Outlets
———————————————————
Total Represented Sector: 12.4 Lakh Pharmacists & Distributors
=========================================================
The Core Dispute: Legislative Overlook and Covid Loopholes
The friction between traditional retailers and internet medicine aggregators centers squarely around a “legal grey area” that traditional pharmacists accuse the central government of ignoring. The AIOCD is demanding the immediate, unconditional withdrawal of two highly controversial government notifications: GSR 817(E) and GSR 220(E).
The first notification, GSR 817(E), was introduced approximately eight years ago as a primitive, introductory draft framework intended to set up basic registration protocols, prescription audits, and functional boundaries for online pharmacies. However, the central government never officially finalized, codified, or formally withdrew this draft. Traditional operators charge that this perpetual legal limbo allows multi-million-dollar online platforms to establish massive digital distribution channels without being bound to the stringent compliance structures enforced on physical stores.
Compounding this issue is notification GSR 220(E), an emergency mandate enacted on March 26, 2020, during the height of the COVID-19 pandemic. To safeguard citizens locked inside their homes, the notification temporarily permitted registered entities to drop off critical medicines right to a patient’s doorstep.
AIOCD General Secretary Rajiv Singhal pointed out that while the policy served an urgent, temporary humanitarian purpose, corporate apps are actively exploiting it as a permanent loophole to justify pan-India mail-order drug dispatch. Traditional chemists state that because the national pandemic crisis ended years ago, this temporary policy must be axed immediately to prevent tech platforms from functioning outside the explicit boundaries of the Drugs and Cosmetics Act, 1940.
Predatory Pricing and Market Distortion
Beyond the structural policy debate, the strike represents a desperate financial stand against aggressive economic displacement. Traditional mom-and-pop pharmacies operating out of residential pockets have found it mathematically impossible to compete with the deep discounting practices utilized by corporate e-pharmacies. Backed by significant venture capital injections, internet delivery platforms regularly offer consumers direct discounts ranging from 20% to as high as 60% on routine prescription refills and daily healthcare products.
“Corporations can effortlessly burn through investor funds to absorb massive financial deficits and corner market share, but a small independent shopkeeper cannot survive on those margins,” the AIOCD remarked in its official strike brief. Independent owners are urging the central government to either ban aggressive online discounting altogether or overhaul the existing Drug Price Control Order (DPCO) to restructure dealer profit margins, giving physical retailers a fair shot at matching online prices without going under.
Public Health Risks: Fake Prescriptions and Drug Abuse
The AIOCD has heavily framed its industrial action around national public safety concerns, accusing digital platforms of utilizing highly relaxed prescription checks. Traditional retail counters are legally obligated to review real physical documents stamped by certified medical practitioners before handing out medications.
In contrast, the association alleges that digital platforms routinely dispense high-risk medications, potent antibiotics, and habit-forming Schedule H and X drugs using poorly verified digital uploads, outdated or reused medical notes, and completely forged doctor documentation. This systemic tracking gap, the AIOCD warns, accelerates the dangerous rise of unchecked self-medication, unregulated prescription abuse, and antibiotic resistance across the country.
Government Actions and Patient Impact
Anticipating widespread medicine shortages, the Central Drugs Standard Control Organisation (CDSCO) stepped in hours before the shutdown, ordering state and union territory drug controllers to deploy swift contingency measures. Authorities held direct negotiations with localized medical bodies to establish “medicine oases”.
As a result, approximately 20% of the country’s distribution network remained operational to handle urgent medical crises. In-house hospital pharmacies, state-run Jan Aushadhi Kendras, and essential emergency rooms functioned as usual to ensure life-saving care was not entirely cut off.
While the strike successfully spotlighted the immense financial strain on local retailers, it also showcased a growing rift within the wider pharmacy industry. Recognizing the CDSCO’s public commitments to launch a thorough regulatory review, several prominent retail associations across West Bengal, Kerala, Punjab, and Uttar Pradesh ultimately withdrew their official strike support to protect vulnerable patients.
The Union Health Ministry has reiterated that while online business formats are expanding, a final, revised national regulatory framework for e-pharmacies is currently undergoing high-level assessment to establish a fair and safe playing field for all market participants.
